Advanced search×

Hematology/Oncology Clinics of North America

Print ISSN
0889-8588
Electronic ISSN
1558-1977
Impact factor
2.778
Publisher
Sciencedirect
URL
http://www.sciencedirect.com/science/journal/08898588
Usage rank
6416
Article count
1826
Free count
6
Free percentage
0.00328587
PDFs via platforms
Sciencedirect and Mdconsult from 1996

  1. Contents
    Author(s) unavailable

    Hematology/Oncology Clinics of North America 29(2):vii (2015)

  2. Copyright
    Author(s) unavailable

    Hematology/Oncology Clinics of North America 29(2):ii (2015)

  3. Bladder Cancer

    Hematology/Oncology Clinics of North America 29(2):i (2015)

  4. Erratum
    Author(s) unavailable

    Hematology/Oncology Clinics of North America 29(2):xv (2015)

  5. Forthcoming Issues
    Author(s) unavailable

    Hematology/Oncology Clinics of North America 29(2):xii (2015)

  6. Contributors
    Author(s) unavailable

    Hematology/Oncology Clinics of North America 29(2):iii (2015)

  7. Copyright
    Author(s) unavailable

    Hematology/Oncology Clinics of North America 29(1):ii (2015)

  8. Preface

    Hematology/Oncology Clinics of North America 29(1) (2015) PMID 25475578

  9. Diet and Lifestyle in Colorectal Cancer Survivors

    Hematology/Oncology Clinics of North America 29(1) (2015) PMID 25475570 PMCID PMC4258898

    Much research supports the association between diet and lifestyle in the development of colorectal cancer. Recent studies have demonstrated an association between various energy balance host factors (obesity, physical inactivity, and certain dietary factors) and outcomes. This review summarizes ...
  10. Nonoperative Management of Rectal Cancer: Identifying the Ideal Patients

    Hematology/Oncology Clinics of North America 29(1):135 (2015) PMID 25475576

    Neoadjuvant chemoradiation (CRT) is considered one of the preferred treatment strategies for patients with locally advanced rectal cancer. This strategy may lead to significant tumor regression, ultimately leading to a complete pathologic response in up to 42% of patients. Assessment o...